<DOC>
	<DOCNO>NCT01784965</DOCNO>
	<brief_summary>The goal study evaluate hypothesis addition liraglutide , long-acting glucagon-like peptide 1 ( GLP-1 ) analogue , calorie-restricted diet lead great weight loss calorie-restricted diet alone subject older ( 50 60 year age ) , overweight/obese , prediabetic . These individual select study greatly increase risk develop type 2 diabetes ( 2DM ) cardiovascular disease ( CVD ) , hypothesize addition liraglutide calorie-restricted diet significantly decrease risk adverse outcomes . There considerable evidence GLP-I compound , include liraglutide , improve glycemic control patient manifest 2DM . However , relatively little information potential utility compound nondiabetic individual greatly increase risk 2DM CVD . This research proposal aim provide information quantify effect liraglutide , long-acting GLP-1 analogue , weight loss , insulin secretion , insulin action , multiple CVD risk factor high risk groupâ€”older , overweight/obese , prediabetic individual . Furthermore , use specific method , surrogate estimate , avoid confound effect glucotoxicity , possible gain new insight effect GLP-1 insulin secretion insulin action .</brief_summary>
	<brief_title>Liraglutide Calorie Restricted Diet Augments Weight Loss Decreases Risk Type 2 Diabetes CVD .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>IFG , IGT BMI 27.037.0 kg/m2 DM , CAD , severe anemia , kidney liver disease , hx pancreatitis , gallstone , ETOH abuse , personnel family history medullary thyroid carcinoma MEN2</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>